// App-Quantinova.ai

231 : Pre-treatment anxiety and depression levels are correlated with less improvement in self-reported disease activity in rheumatoid arthritis patients treated with biological therapy: results from the BRAGGSS cohort

Researchers

Presenter

  • Sarah Dyball

Principal Investigators

  • Lis Cordingley

  • John D Isaacs

  • Gerry Wilson

  • Ann Morgan

  • Kimme Hyrich

  • Darren Plant

  • Anne Barton

Medical Centers

  • Arthritis Research UK Centre for Genetics and Genomics, University of Manchester, Manchester, United Kingdom

  • Division of Musculoskeletal and Dermatological Sciences, Manchester Academic Health Science Centre, University of Manchester, UNITED KINGDOM

  • Institute of Cellular Medicine, Newcastle University, Newcastle-Upon-Tyne, UNITED KINGDOM

  • National Institute for Health Research, Newcastle Biomedical Research Centre, Newcastle University, UNITED KINGDOM

  • Genomic Medicine, University of Sheffield, Sheffield, UNITED KINGDOM

  • Leeds Institute of Rheumatic and Musculoskeletal Molecular Medicine, St James's University Hospital, Leeds, UNITED KINGDOM

  • National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust, Manchester, UNITED KINGDOM

  • Arthritis Research UK Centre for Genetics and Genomics, Institute of Inflammation and Repair, University of Manchester, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Rheumatoid arthritis

  • Depression

  • Inflammatory Arthritis

  • Anxiety

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved